Disseminated herpes zoster following treatment with benralizumab.
Ajay Kumar MishraKamal Kant SahuAtem JamesPublished in: The clinical respiratory journal (2019)
Clinical trials have reported an association of mepolizumab, another anti-IL-5 monoclonal antibody with herpes zoster. This report of herpes zoster following initiation of benralizumab might suggest a possibility of a class effect of anti-IL-5 monoclonal antibody.